A. Ackerman, MD,PhD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)
    Ineligible company: 
    Abbvie
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (General Urology)
    Ineligible company: 
    MicrogenDx
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Watershed Medical
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Female Pelvic Medicine & Reconstructive Surgery)
    Ineligible company: 
    Cynosure
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Scientific Study or Trial (Female Pelvic Medicine & Reconstructive Surgery)
    Ineligible company: 
    Medtronic
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
Return to Update Series (2022) Lesson 30: Asymptomatic Bacteriuria, Atypical Urinary Tract Infection, and the Urinary Microbiome: Implications for the Practicing Clinician